| 757688 |
FRONTIERS IN ONCOLOGY |
Grade 4 Neutropenia Secondary to Immune Checkpoint Inhibition — A Descriptive Observational Retrospective Multicenter Analysis |
2021-10-21 |
10.3389/fonc.2021.765608 |
Zaremba Anne, Kramer Rafaela, De Temple Viola, Bertram Stefanie, Salzmann Martin, Gesierich Anja, Reinhardt Lydia, Baroudjian Barouyr, Sachse Michael M., Mechtersheimer Gunhild, Johnson Douglas B., Weppler Alison M., Spain Lavinia, Loquai Carmen, Dudda Milena, Pföhler Claudia, Hepner Adriana, Long Georgina V., Menzies Alexander M., Carlino Matteo S., Lebbé Céleste, Enokida Tomohiro, Tahara Makoto, Bröckelmann Paul J., Eigentler Thomas, Kähler Katharina C., Gutzmer Ralf, Berking Carola, Ugurel Selma, Stadtler Nadine, Sucker Antje, Becker Jürgen C., Livingstone Elisabeth, Meier Friedegund, Hassel Jessica C., Schadendorf Dirk, Hanoun Maher, Heinzerling Lucie, Zimmer Lisa |
| 757687 |
FRONTIERS IN ONCOLOGY |
Safety Profile of Oxaliplatin in 3,687 Patients With Cancer in China: A Post-Marketing Surveillance Study |
2021-10-21 |
10.3389/fonc.2021.757196 |
Yu Zaoqin, Huang Rui, Zhao Li, Wang Ximin, Shangguan Xiaofang, Li Wei, Li Min, Yin Xianguo, Zhang Chengliang, Liu Dong |
| 757686 |
FRONTIERS IN ONCOLOGY |
Predicting the Initial Treatment Response to Transarterial Chemoembolization in Intermediate-Stage Hepatocellular Carcinoma by the Integration of Radiomics and Deep Learning |
2021-10-21 |
10.3389/fonc.2021.730282 |
Peng Jie, Huang Jinhua, Huang Guijia, Zhang Jing |
| 757685 |
FRONTIERS IN ONCOLOGY |
RIPK3 and AXL Expression Study in Primary Cutaneous Melanoma Unmasks AXL as Predictor of Sentinel Node Metastasis: A Pilot Study |
2021-10-21 |
10.3389/fonc.2021.728319 |
Nicolè Lorenzo, Cappello Filippo, Cappellesso Rocco, Piccin Luisa, Ventura Laura, Guzzardo Vincenza, Del Fiore Paolo, Chiarion-Sileni Vanna, Dei Tos Angelo Paolo, Mocellin Simone, Fassina Ambrogio |
| 757684 |
FRONTIERS IN ONCOLOGY |
Identification of a Three-Gene Signature Based on Epithelial-Mesenchymal Transition of Lung Adenocarcinoma Through Construction and Validation of a Risk-Prediction Model |
2021-10-21 |
10.3389/fonc.2021.726834 |
Shi Jianguang, Wang Zishan, Guo Jing, Chen Yingqi, Tong Changyong, Tong Jingjie, Hu Wentao, Li Chenwei, Li Xinjian |
| 757683 |
FRONTIERS IN ONCOLOGY |
Association Between Traditional Herbal Diet and Nasopharyngeal Carcinoma Risk: A Prospective Cohort Study in Southern China |
2021-10-21 |
10.3389/fonc.2021.715242 |
Lyu Yun-Hong, Lin Chu-Yang, Xie Shang-Hang, Li Tong, Liu Qing, Ling Wei, Lu Yu-Qiang, Cao Su-Mei, Lin Ai-Hua |
| 757682 |
FRONTIERS IN ONCOLOGY |
Hematological Toxicities of Concurrent Chemoradiotherapies in Head and Neck Cancers: Comparison Among Cisplatin, Nedaplatin, Lobaplatin, and Nimotuzumab |
2021-10-21 |
10.3389/fonc.2021.762366 |
Wu Qiuji, Zhu Chunmei, Zhang Shuyuan, Zhou Yunfeng, Zhong Yahua |
| 757681 |
FRONTIERS IN ONCOLOGY |
Prediction of Breast Cancer Recurrence Using a Deep Convolutional Neural Network Without Region-of-Interest Labeling |
2021-10-21 |
10.3389/fonc.2021.734015 |
Phan Nam Nhut, Hsu Chih-Yi, Huang Chi-Cheng, Tseng Ling-Ming, Chuang Eric Y. |
| 757680 |
FRONTIERS IN ONCOLOGY |
Generation of Two Paclitaxel-Resistant High-Grade Serous Carcinoma Cell Lines With Increased Expression of P-Glycoprotein |
2021-10-21 |
10.3389/fonc.2021.752127 |
Nunes Mariana, Silva Patrícia M. A., Coelho Ricardo, Pinto Carla, Resende Albina, Bousbaa Hassan, Almeida Gabriela M., Ricardo Sara |
| 757679 |
FRONTIERS IN ONCOLOGY |
Gastrointestinal Cancers and Liver Cirrhosis: Implications on Treatments and Prognosis |
2021-10-21 |
10.3389/fonc.2021.766069 |
Xiang Ze, Li Yiqi, Zhu Chaojie, Hong Tu, He Xianglin, Zhu Hua, Jiang Danbin |
